Cameroon

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
4.22 (3.81 - 4.55)	2019	Modelled	IHME
4.45 (4 - 4.75)	2018	Modelled	IHME
4.59 (4.09 - 4.93)	2017	Modelled	IHME
4.64 (4.14 - 4.98)	2016	Modelled	IHME
4.69 (4.14 - 5.06)	2015	Modelled	IHME
4.78 (4.21 - 5.16)	2014	Modelled	IHME
4.91 (4.35 - 5.31)	2013	Modelled	IHME
5.06 (4.53 - 5.49)	2012	Modelled	IHME
5.21 (4.71 - 5.64)	2011	Modelled	IHME
5.35 (4.88 - 5.77)	2010	Modelled	IHME
5.46 (5.07 - 5.80)	2009	Modelled	IHME
5.57 (5.25 - 5.84)	2008	Modelled	IHME
5.68 (5.43 - 5.90)	2007	Modelled	IHME
5.8 (5.60 - 5.98)	2006	Modelled	IHME
5.92 (5.76 - 6.08)	2005	Modelled	IHME
6.09 (5.94 - 6.22)	2004	Modelled	IHME
6.29 (6.14 - 6.43)	2003	Modelled	IHME
6.49 (6.32 - 6.67)	2002	Modelled	IHME
6.66 (6.46 - 6.87)	2001	Modelled	IHME
6.75 (6.53 - 6.99)	2000	Modelled	IHME
6.79 (6.58 - 7.01)	1999	Modelled	IHME
6.82 (6.60 - 7.04)	1998	Modelled	IHME
6.84 (6.62 - 7.06)	1997	Modelled	IHME
6.86 (6.64 - 7.09)	1996	Modelled	IHME
6.9 (6.67 - 7.13)	1995	Modelled	IHME
6.95 (6.73 - 7.18)	1994	Modelled	IHME
7.04 (6.81 - 7.27)	1993	Modelled	IHME
7.14 (6.91 - 7.39)	1992	Modelled	IHME
7.27 (7.02 - 7.53)	1991	Modelled	IHME
7.4 (7.13 - 7.68)	1990	Modelled	IHME
8.3 (6.50 - 10.20)	2017	Survey/reported	Cameroon Population-based HIV Impact Assessment (CAMPHIA) 2017, 2020
4.43 (3.49 - 5.73)	2015	Modelled	WHO

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
1.02 (0.84 - 1.22)	2019	Modelled	IHME
1.11 (0.89 - 1.29)	2018	Modelled	IHME
1.2 (0.95 - 1.38)	2017	Modelled	IHME
1.29 (1.02 - 1.48)	2016	Modelled	IHME
1.37 (1.10 - 1.59)	2015	Modelled	IHME
1.43 (1.16 - 1.65)	2014	Modelled	IHME
1.48 (1.19 - 1.70)	2013	Modelled	IHME
1.52 (1.23 - 1.75)	2012	Modelled	IHME
1.56 (1.26 - 1.80)	2011	Modelled	IHME
1.61 (1.27 - 1.86)	2010	Modelled	IHME
1.65 (1.33 - 1.88)	2009	Modelled	IHME
1.68 (1.39 - 1.90)	2008	Modelled	IHME
1.71 (1.44 - 1.92)	2007	Modelled	IHME
1.76 (1.51 - 1.96)	2006	Modelled	IHME
1.82 (1.58 - 2.02)	2005	Modelled	IHME
2.21 (1.96 - 2.42)	2004	Modelled	IHME
3.01 (2.67 - 3.32)	2003	Modelled	IHME
3.96 (3.52 - 4.38)	2002	Modelled	IHME
4.76 (4.20 - 5.30)	2001	Modelled	IHME
5.15 (4.51 - 5.75)	2000	Modelled	IHME
5.21 (4.62 - 5.81)	1999	Modelled	IHME
5.25 (4.70 - 5.86)	1998	Modelled	IHME
5.28 (4.74 - 5.87)	1997	Modelled	IHME
5.32 (4.77 - 5.94)	1996	Modelled	IHME
5.36 (4.79 - 6.01)	1995	Modelled	IHME
5.42 (4.88 - 6.06)	1994	Modelled	IHME
5.49 (4.94 - 6.12)	1993	Modelled	IHME
5.57 (4.98 - 6.21)	1992	Modelled	IHME
5.65 (5 - 6.34)	1991	Modelled	IHME
5.75 (4.96 - 6.49)	1990	Modelled	IHME
1.9 (1.34 - 2.61)	2015	Modelled	WHO

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
7.19 (4.82 - 10.30)	2019	Modelled	IHME
7.28 (4.88 - 10.40)	2018	Modelled	IHME
7.41 (4.99 - 10.40)	2017	Modelled	IHME
7.51 (5.08 - 10.60)	2016	Modelled	IHME
7.69 (5.21 - 10.70)	2015	Modelled	IHME
8.1 (5.49 - 11.40)	2014	Modelled	IHME
8.54 (5.83 - 11.80)	2013	Modelled	IHME
8.99 (6.12 - 12.30)	2012	Modelled	IHME
9.48 (6.47 - 12.80)	2011	Modelled	IHME
9.87 (6.76 - 13.20)	2010	Modelled	IHME
10.1 (7.05 - 13.40)	2009	Modelled	IHME
10.4 (7.27 - 13.80)	2008	Modelled	IHME
10.8 (7.68 - 14.20)	2007	Modelled	IHME
11.3 (8.03 - 14.80)	2006	Modelled	IHME
11.7 (8.17 - 15.40)	2005	Modelled	IHME
12.1 (8.44 - 16)	2004	Modelled	IHME
12.6 (8.82 - 17.50)	2003	Modelled	IHME
13.1 (9.09 - 19.20)	2002	Modelled	IHME
13.3 (9.28 - 19.80)	2001	Modelled	IHME
13.4 (9.30 - 19.50)	2000	Modelled	IHME
13.3 (9.40 - 19.10)	1999	Modelled	IHME
13.4 (9.34 - 19.10)	1998	Modelled	IHME
13.4 (9.35 - 18.90)	1997	Modelled	IHME
13.3 (9.31 - 18.80)	1996	Modelled	IHME
13.3 (9.30 - 18.80)	1995	Modelled	IHME
13.4 (9.28 - 19)	1994	Modelled	IHME
13.4 (9.41 - 19.20)	1993	Modelled	IHME
13.4 (9.39 - 19.10)	1992	Modelled	IHME
13.4 (9.34 - 19.30)	1991	Modelled	IHME
13.5 (9.37 - 19.60)	1990	Modelled	IHME

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
2,092 (1,402 - 2,987)	2019	Modelled	IHME
2,060 (1,382 - 2,930)	2018	Modelled	IHME
2,038 (1,373 - 2,870)	2017	Modelled	IHME
2,006 (1,358 - 2,844)	2016	Modelled	IHME
1,993 (1,351 - 2,769)	2015	Modelled	IHME
2,035 (1,381 - 2,855)	2014	Modelled	IHME
2,079 (1,420 - 2,878)	2013	Modelled	IHME
2,118 (1,441 - 2,891)	2012	Modelled	IHME
2,158 (1,473 - 2,915)	2011	Modelled	IHME
2,171 (1,485 - 2,905)	2010	Modelled	IHME
2,146 (1,496 - 2,842)	2009	Modelled	IHME
2,132 (1,486 - 2,814)	2008	Modelled	IHME
2,137 (1,513 - 2,790)	2007	Modelled	IHME
2,149 (1,523 - 2,814)	2006	Modelled	IHME
2,138 (1,492 - 2,814)	2005	Modelled	IHME
2,124 (1,483 - 2,804)	2004	Modelled	IHME
2,135 (1,489 - 2,960)	2003	Modelled	IHME
2,136 (1,477 - 3,111)	2002	Modelled	IHME
2,085 (1,449 - 3,086)	2001	Modelled	IHME
2,016 (1,397 - 2,928)	2000	Modelled	IHME
1,929 (1,359 - 2,763)	1999	Modelled	IHME
1,870 (1,299 - 2,657)	1998	Modelled	IHME
1,794 (1,252 - 2,533)	1997	Modelled	IHME
1,719 (1,201 - 2,423)	1996	Modelled	IHME
1,657 (1,155 - 2,335)	1995	Modelled	IHME
1,602 (1,111 - 2,280)	1994	Modelled	IHME
1,552 (1,086 - 2,217)	1993	Modelled	IHME
1,495 (1,046 - 2,122)	1992	Modelled	IHME
1,445 (1,005 - 2,081)	1991	Modelled	IHME
1,400 (973 - 2,039)	1990	Modelled	IHME
3,567	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
49 (41 - 58)	2019	Modelled	IHME
49 (41 - 58)	2018	Modelled	IHME
49 (40 - 58)	2017	Modelled	IHME
49 (41 - 58)	2016	Modelled	IHME
49 (41 - 58)	2015	Modelled	IHME
50 (41 - 59)	2014	Modelled	IHME
50 (42 - 59)	2013	Modelled	IHME
51 (42 - 59)	2012	Modelled	IHME
51 (43 - 60)	2011	Modelled	IHME
52 (43 - 60)	2010	Modelled	IHME
52 (43 - 60)	2009	Modelled	IHME
52 (43 - 60)	2008	Modelled	IHME
52 (43 - 60)	2007	Modelled	IHME
52 (43 - 60)	2006	Modelled	IHME
52 (43 - 60)	2005	Modelled	IHME
52 (43 - 61)	2004	Modelled	IHME
52 (43 - 61)	2003	Modelled	IHME
52 (43 - 61)	2002	Modelled	IHME
53 (44 - 61)	2001	Modelled	IHME
53 (44 - 61)	2000	Modelled	IHME
53 (44 - 61)	1999	Modelled	IHME
53 (44 - 61)	1998	Modelled	IHME
52 (44 - 61)	1997	Modelled	IHME
52 (44 - 61)	1996	Modelled	IHME
52 (43 - 61)	1995	Modelled	IHME
52 (43 - 61)	1994	Modelled	IHME
52 (43 - 61)	1993	Modelled	IHME
51 (43 - 60)	1992	Modelled	IHME
51 (43 - 60)	1991	Modelled	IHME
51 (42 - 60)	1990	Modelled	IHME

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
79	2018	Survey/reported	WHO/UNICEF
86	2017	Survey/reported	WHO/UNICEF
85	2016	Survey/reported	WHO/UNICEF
84	2015	Survey/reported	WHO/UNICEF
87	2014	Survey/reported	WHO/UNICEF
89	2013	Survey/reported	WHO/UNICEF
85	2012	Survey/reported	WHO/UNICEF
82	2011	Survey/reported	WHO/UNICEF
84	2010	Survey/reported	WHO/UNICEF
80	2009	Survey/reported	WHO/UNICEF
84	2008	Survey/reported	WHO/UNICEF
82	2007	Survey/reported	WHO/UNICEF
81	2006	Survey/reported	WHO/UNICEF
79	2005	Survey/reported	WHO/UNICEF

Showing out of

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
0 (0 - 0)	2016	Survey/reported	Harm Reduction International, 2016

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
0	2016	Survey/reported	Harm Reduction International, 2016

HBV National Action Plan

HBV elimination goal

HepB birth dose policy

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

HCV elimination goal

Eligible for HCV generic medicines

Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
2.62 (2.10 - 3.31)	2019	Modelled	IHME
2.63 (2.10 - 3.32)	2018	Modelled	IHME
2.63 (2.11 - 3.32)	2017	Modelled	IHME
2.63 (2.12 - 3.31)	2016	Modelled	IHME
2.64 (2.12 - 3.31)	2015	Modelled	IHME
2.66 (2.15 - 3.34)	2014	Modelled	IHME
2.71 (2.18 - 3.39)	2013	Modelled	IHME
2.76 (2.21 - 3.47)	2012	Modelled	IHME
2.8 (2.25 - 3.52)	2011	Modelled	IHME
2.83 (2.27 - 3.57)	2010	Modelled	IHME
2.83 (2.28 - 3.55)	2009	Modelled	IHME
2.83 (2.29 - 3.53)	2008	Modelled	IHME
2.83 (2.29 - 3.53)	2007	Modelled	IHME
2.83 (2.30 - 3.53)	2006	Modelled	IHME
2.83 (2.30 - 3.52)	2005	Modelled	IHME
2.84 (2.31 - 3.53)	2004	Modelled	IHME
2.86 (2.33 - 3.56)	2003	Modelled	IHME
2.89 (2.36 - 3.59)	2002	Modelled	IHME
2.93 (2.38 - 3.65)	2001	Modelled	IHME
2.98 (2.41 - 3.71)	2000	Modelled	IHME
3.08 (2.50 - 3.79)	1999	Modelled	IHME
3.26 (2.66 - 3.96)	1998	Modelled	IHME
3.46 (2.86 - 4.16)	1997	Modelled	IHME
3.65 (3.03 - 4.35)	1996	Modelled	IHME
3.8 (3.13 - 4.50)	1995	Modelled	IHME
3.9 (3.23 - 4.61)	1994	Modelled	IHME
3.99 (3.31 - 4.70)	1993	Modelled	IHME
4.07 (3.37 - 4.81)	1992	Modelled	IHME
4.14 (3.41 - 4.90)	1991	Modelled	IHME
4.18 (3.43 - 4.97)	1990	Modelled	IHME

Showing out of

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
11.6 (4.30 - 29.70)	2014	Modelled	Gower et al, 2014

HCV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
0.93 (0.58 - 1.43)	2019	Modelled	IHME
0.95 (0.59 - 1.46)	2018	Modelled	IHME
0.96 (0.59 - 1.48)	2017	Modelled	IHME
0.96 (0.59 - 1.47)	2016	Modelled	IHME
0.96 (0.58 - 1.48)	2015	Modelled	IHME
0.98 (0.59 - 1.49)	2014	Modelled	IHME
0.98 (0.59 - 1.50)	2013	Modelled	IHME
0.99 (0.60 - 1.50)	2012	Modelled	IHME
1 (0.61 - 1.51)	2011	Modelled	IHME
1.03 (0.64 - 1.52)	2010	Modelled	IHME
1.05 (0.66 - 1.54)	2009	Modelled	IHME
1.07 (0.67 - 1.58)	2008	Modelled	IHME
1.1 (0.70 - 1.63)	2007	Modelled	IHME
1.13 (0.73 - 1.65)	2006	Modelled	IHME
1.15 (0.75 - 1.67)	2005	Modelled	IHME
1.17 (0.77 - 1.69)	2004	Modelled	IHME
1.2 (0.79 - 1.71)	2003	Modelled	IHME
1.22 (0.81 - 1.75)	2002	Modelled	IHME
1.23 (0.82 - 1.77)	2001	Modelled	IHME
1.25 (0.84 - 1.79)	2000	Modelled	IHME
1.25 (0.86 - 1.76)	1999	Modelled	IHME
1.26 (0.86 - 1.78)	1998	Modelled	IHME
1.26 (0.88 - 1.75)	1997	Modelled	IHME
1.25 (0.87 - 1.77)	1996	Modelled	IHME
1.25 (0.87 - 1.76)	1995	Modelled	IHME
1.26 (0.87 - 1.77)	1994	Modelled	IHME
1.27 (0.88 - 1.77)	1993	Modelled	IHME
1.27 (0.88 - 1.76)	1992	Modelled	IHME
1.28 (0.89 - 1.78)	1991	Modelled	IHME
1.29 (0.91 - 1.80)	1990	Modelled	IHME

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
270 (168 - 417)	2019	Modelled	IHME
268 (166 - 415)	2018	Modelled	IHME
265 (162 - 406)	2017	Modelled	IHME
256 (158 - 392)	2016	Modelled	IHME
248 (151 - 385)	2015	Modelled	IHME
246 (148 - 374)	2014	Modelled	IHME
240 (144 - 365)	2013	Modelled	IHME
233 (141 - 353)	2012	Modelled	IHME
229 (139 - 344)	2011	Modelled	IHME
226 (141 - 335)	2010	Modelled	IHME
222 (140 - 327)	2009	Modelled	IHME
218 (138 - 323)	2008	Modelled	IHME
216 (137 - 321)	2007	Modelled	IHME
214 (138 - 313)	2006	Modelled	IHME
210 (137 - 304)	2005	Modelled	IHME
206 (134 - 296)	2004	Modelled	IHME
203 (134 - 289)	2003	Modelled	IHME
199 (132 - 285)	2002	Modelled	IHME
193 (128 - 277)	2001	Modelled	IHME
188 (127 - 268)	2000	Modelled	IHME
181 (124 - 255)	1999	Modelled	IHME
176 (119 - 248)	1998	Modelled	IHME
168 (118 - 235)	1997	Modelled	IHME
161 (112 - 228)	1996	Modelled	IHME
156 (108 - 219)	1995	Modelled	IHME
151 (105 - 212)	1994	Modelled	IHME
146 (102 - 204)	1993	Modelled	IHME
142 (98 - 197)	1992	Modelled	IHME
138 (96 - 191)	1991	Modelled	IHME
134 (94 - 187)	1990	Modelled	IHME
1,083	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
14 (10 - 20)	2019	Modelled	IHME
14 (10 - 20)	2018	Modelled	IHME
14 (10 - 20)	2017	Modelled	IHME
14 (10 - 20)	2016	Modelled	IHME
14 (10 - 20)	2015	Modelled	IHME
14 (10 - 20)	2014	Modelled	IHME
14 (10 - 20)	2013	Modelled	IHME
14 (10 - 19)	2012	Modelled	IHME
14 (9 - 19)	2011	Modelled	IHME
14 (9 - 19)	2010	Modelled	IHME
14 (10 - 19)	2009	Modelled	IHME
14 (10 - 19)	2008	Modelled	IHME
14 (10 - 19)	2007	Modelled	IHME
14 (10 - 20)	2006	Modelled	IHME
14 (10 - 20)	2005	Modelled	IHME
14 (10 - 20)	2004	Modelled	IHME
14 (10 - 20)	2003	Modelled	IHME
14 (10 - 20)	2002	Modelled	IHME
14 (10 - 20)	2001	Modelled	IHME
14 (10 - 20)	2000	Modelled	IHME
15 (10 - 20)	1999	Modelled	IHME
15 (10 - 20)	1998	Modelled	IHME
15 (10 - 20)	1997	Modelled	IHME
15 (10 - 21)	1996	Modelled	IHME
15 (10 - 21)	1995	Modelled	IHME
15 (10 - 21)	1994	Modelled	IHME
16 (10 - 22)	1993	Modelled	IHME
16 (11 - 22)	1992	Modelled	IHME
16 (11 - 22)	1991	Modelled	IHME
16 (11 - 22)	1990	Modelled	IHME

Showing out of

Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)

Download

Value	Year	Type	Source
300 (0 - 0)	2016	Survey/reported	Harm Reduction International, 2016

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
0	2016	Survey/reported	Harm Reduction International, 2016

HBV National Action Plan

HBV elimination goal

HepB birth dose policy

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

HCV elimination goal

Eligible for HCV generic medicines

Source: WHO

Overview

HBV elimination goal

HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)

4.22 (%)

2019

(3.81 - 4.55(%))

IHME

HCV (RNA/cAg+)

2.62 (%)

2019

(2.1 - 3.31(%))

IHME

Survey/surveillance

HBV (HBsAg+)

8.3 (%)

2017

(6.5 - 10.2(%))

Cameroon Population-based HIV Impact Assessment (CAMPHIA) 2017, 2020

No data available

Hepatitis related deaths (national)

Modelled

HBV

2,092

2019

(1,402 - 2,987)

IHME

Survey/surveillance

No data available

HBV chart

Modelled

HCV

270

2019

(168 - 417)

IHME

Survey/surveillance

No data available

HCV chart

Prevalence < 5

HBV

1.02 (%)

2019, latest modelled

(0.84 - 1.22(%))

IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV

2016

(0 - 0)

Harm Reduction International, 2016

Eligible for HBV generic medicines

Eligible for HCV generic medicines

Resources

Data

Deriving the optimal limit of detection for an HCV point-of-care test viraemic infection: Analysis of a global dataset

23 Jul 2019

Journal of Hepatology

Hepatitis C

Hepatitis B

Implementation

Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets

01 Dec 2017

Hepatitis B

Policy

Prevention, Care and Treatment of Viral Hepatitis in The African Region: Framework for Action, 2016 - 2020

Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis (Journal article)

28 Aug 2017

BMJ Open. 2017; 7(8): e015748. Published online 2017 Aug 28. doi: 10.1136/bmjopen-2016-015748

Hepatitis C